Division of Nephrology, ICMR Center for Advanced Research in Nephrology, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, 110029, India.
Division of Pediatric Pulmonology & Intensive Care, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India.
Indian J Pediatr. 2023 Apr;90(4):355-361. doi: 10.1007/s12098-022-04214-z. Epub 2022 Jul 4.
To examine the feasibility, efficacy, and safety of sustained low-efficiency dialysis (SLED) in hemodynamically unstable, critically ill children.
Critically ill patients, 1-18 y old with hemodynamic instability (≥ 1 vasoactive drugs) and severe acute kidney injury (AKI) requiring kidney replacement therapy (KRT) in a tertiary care pediatric intensive care unit were prospectively enrolled. Patients weighing ≤ 8 kg or with mean arterial pressure < 5 percentile despite > 3 vasoactive drugs, were excluded. Patients underwent SLED until hemodynamically stable and off vasoactive drugs, or lack of need for dialysis. The primary outcome was the proportion of patients in whom the first session of SLED was initiated within 12 h of its indication and completed without premature (< 6 h) termination. Efficacy was estimated by ultrafiltration, urea reduction ratio (URR), and equilibrated Kt/V. Other outcomes included: changes in hemodynamic scores, circuit clotting, adverse events, and changes in indices on point-of-care ultrasonography and echocardiography.
Between November 2018 and March 2020, 18 patients with median age 8.6 y and vasopressor dependency index of 83.2, underwent 41 sessions of SLED. In 16 patients, SLED was feasible within 12 h of indication. No session was terminated prematurely. Ultrafiltration achieved was 4.0 ± 2.2 mL/kg/h, while URR was 57.7 ± 16.2% and eKt/V 1.17 ± 0.56. Hemodynamic scores did not change significantly. Asymptomatic hypokalemia was the chief adverse effect. Sessions were associated with a significant improvement in indices on ultrasound and left ventricular function. Fourteen patients died.
SLED is feasible, safe, and effective in enabling KRT in hemodynamically unstable children with severe AKI.
研究持续低效率透析(SLED)在血流动力学不稳定的危重儿童中的可行性、疗效和安全性。
本前瞻性研究纳入了一家三级儿童重症监护病房中血流动力学不稳定(≥1 种血管活性药物)且需要肾脏替代治疗(KRT)的严重急性肾损伤(AKI)的 1-18 岁危重患儿。体重≤8kg 或平均动脉压尽管使用了>3 种血管活性药物仍<第 5 百分位数的患者被排除在外。患者接受 SLED 治疗,直至血流动力学稳定且停用血管活性药物,或无需透析。主要结局是首次 SLED 治疗在其适应证后 12 小时内开始且未提前(<6 小时)终止的患者比例。超滤、尿素清除率(URR)和平衡 Kt/V 用于评估疗效。其他结局包括:血流动力学评分变化、回路凝血、不良事件以及床旁超声心动图和超声检查指数变化。
2018 年 11 月至 2020 年 3 月,18 名平均年龄 8.6 岁、血管加压素依赖指数为 83.2 的患儿接受了 41 次 SLED 治疗。在 16 名患儿中,SLED 在适应证后 12 小时内是可行的。没有提前终止任何一次治疗。实现的超滤量为 4.0±2.2mL/kg/h,URR 为 57.7±16.2%,eKt/V 为 1.17±0.56。血流动力学评分无显著变化。无症状低钾血症是主要的不良事件。SLED 治疗与超声和左心室功能指数的显著改善相关。14 名患儿死亡。
SLED 在血流动力学不稳定伴有严重 AKI 的儿童中实施 KRT 是可行、安全且有效的。